Table 1.
IL | QTL | Na | Disease incidence (%) | Lesion size (mm) | Lesion growth rate (mm/day) |
---|---|---|---|---|---|
1–1 | 41 | 65 ± 6.7 | 56 | 5.9 | |
1–2 | Rbcq1? | 40 | 47 ± 6.7 | 33 | 3.4 |
1–3 / 3–3 | Rbcq9b | 29 | 45 ± 9.1** | 30** | 1.7** |
1–4 | Rbcq9b | 44 | 37 ± 6.4** | 34 | 2.4* |
2–1 | Rbcq2 | 44 | 41 ± 6.4** | 30* | 3.0 |
2–2 | Rbcq2 | 44 | 37 ± 6.5** | 26* | 2.8 |
2–3 | 44 | 58 ± 6.5 | 44 | 3.5 | |
3–1 | Rbcq3 | 43 | 47 ± 6.6 | 41 | 2.8* |
3–2 | Rbcq3 | 44 | 46 ± 6.5* | 35 | 4.2 |
4–1 | Rbcq4a | 44 | 41 ± 6.4** | 26** | 2.5* |
4–2 | Rbcq4a | 42 | 45 ± 6.7* | 33 | 3.8 |
4–3 | Rbcq4b, Rbcq9a | 20 | 51 ± 9.6 | 29 | 2.8 |
5–1 | 44 | 61 ± 6.6 | 53 | 4.8 | |
5–2 | 43 | 69 ± 6.6 | 64 | 5.4 | |
6–1 | Rbcq6 | 44 | 49 ± 6.5* | 44 | 3.6 |
6–2 / 7–2 | 44 | 55 ± 6.3 | 39 | 3.7 | |
6–3 | 44 | 79 ± 6.5 | 49 | 4.6 | |
7–1 | 44 | 50 ± 6.4 | 35 | 3.1 | |
8–3 | 44 | 59 ± 6.5 | 43 | 3.9 | |
9–1 | Rbcq9a | 44 | 69 ± 6.5 | 34* | 3.0* |
9–2 | Rbcq9b | 44 | 49 ± 6.4* | 33 | 3.1 |
10–1 | 43 | 60 ± 6.6 | 47 | 4.3 | |
10–2 | 44 | 62 ± 6.5 | 49 | 4.4 | |
10–3 | 44 | 70 ± 6.4 | 53 | 4.7 | |
10–4 | 44 | 76 ± 6.6 | 47 | 4.8 | |
11–1 / 9–3 | Rbcq9b | 44 | 48 ± 6.5* | 36 | 4.3 |
11–2 | Rbcq11 | 44 | 34 ± 6.4** | 33* | 3.2 |
12–1 | Rbcq12 | 44 | 51 ± 6.4 | 35 | 4.7 |
12–2 | Rbcq12 | 43 | 52 ± 6.4 | 37 | 4.0 |
12–3 | Rbcq9b, Rbcq12 | 24 | 24 ± 8.6** | 21** | 2.3 |
SL | 156 | 73 ± 4.0 | 46 | 4.6 | |
SH | 44 | 3 ± 6.4** | NDb | ||
BRC-5 | Rbcq1 andRbcq4b | 39 | 15 ± 6.9** | 20* | NDc |
Durinta | 68 | 42 ± 5.5** | 29** | 2.3** |
aN Number of inoculation sites
bOnly one outgrowing lesion, observation excluded from the statistical analysis
cFirst observation of outgrowing lesions was after 12 days, therefore lesion growth could not be determined